Company intelligence / Profile preview

Grand Medical Group

Luzern, Lucerne, Switzerlandgrandmedicalgroup.ch ↗
Ownership
Private
Development stage
Other
01

Overview

Over 75 branded pharma, OTC, and supplement products and 320+ market registrations across Europe, Asia, Africa; strong commercial footprint in key therapeutic sectors

Therapeutic areas
ImmunologyEndocrinologyMen's HealthInfectious DiseasesGastroenterologyCardiovascularNeurologyWomen's Health
Modalities
Small moleculeBiologicHerbal compoundSynthetic compound
Industry
Biotech
02

Drug pipeline

14 assets

Treataprost

Preclinical

13 more assets in the full pipeline.

03

Partnerships

Contract manufacturingStrategic alliances

Beyond the preview

Go deeper on Grand Medical Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Grand Medical Group.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call